Skip to main content
SpringerLink
Log in

Release of phosphodiesterase activator from particulate fractions of cerebellum and striatum by putative neurotransmitters

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The endogenous phosphodiesterase activator (PDEA) described by Cheung (1,2) is, in part, stored as a membrane-bound protein (12,13). PDEA can be released from the membranes by a cAMP-dependent phosphorylation of a protein that may function as PDEA binding site (13). We found that PDEA can be released from brain particulate fraction by 1 μM norepinephrine, dopamine, adenosine, and histamine in the presence of ATP and a purified cAMP-dependent protein kinase; in similar conditions, serotonin is ineffective in concentrations up to 0.1 mM. Norepinephrine and dopamine activate the adenylate cyclase activity of those preparations from which they release the PDEA. Norepinephrine is more potent than dopamine in releasing PDEA from the particulate fraction of cerebellum, whereas dopamine is more active than norepinephrine in releasing PDEA from the particulate fraction of striatum. The release of PDEA elicited by both neurotransmitters is concentration-dependent; increasing the transmitter concentrations above a certain limit decreases the rate of PDEA release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cheung, W.Y. (1970) Cyclic 3′,5′-nucleotide phosphodiesterase: demonstration of an activator. Biochem. Biophys. Res. Commun. 38, 533–538.

    PubMed  Google Scholar 

  2. Cheung, W.Y. (1971) Cyclic 3′,5′-nucleotide phosphodiesterase: evidence for and properties of a protein activator. J. Biol. Chem. 246, 2859–2869.

    PubMed  Google Scholar 

  3. Liu, Y.P., Lin, Y.M., andCheung, W.Y. (1974) Active form of protein activator of cAMP phosphodiesterase is a Ca++-activator complex. Fed. Proc. Fed. Am. Soc. Exp. Biol. 33, 1391.

    Google Scholar 

  4. Lin, Y.M., Liu, Y.P., andCheung, W.Y. (1974) Purification and characterization of a protein activator of cyclic nucleotide phosphodiesterase from bovine brain.In Hardman, J.G., andO'Malley, B.W. (eds.), Methods in Enzymology, Vol. 38, Academic Press, Inc. New York, pp. 262–283.

    Google Scholar 

  5. Lin, Y.M., Liu, Y.P., andCheung, W.Y. (1974) Cyclic 3′,5′-nucleotide phosphodiesterase. Purification, characterization, and active form of the protein activator from bovine brain. J. Biol. Chem. 249, 4943–4954.

    PubMed  Google Scholar 

  6. Kakiuchi, S., andYamazaki, R. (1970) Calcium dependent phosphodiesterase activity and its, activating factor (PAF) from brain: studies on cyclic 3′,5′-nucleotide phosphodiesterase (III). Biochem. Biophys. Res. Commun. 41, 1104–1110.

    PubMed  Google Scholar 

  7. Kakiuchi, S., Yamazaki, R., andNakajima, H. (1970) Properties of a heat-stable phosphodiesterase activating factor isolated from brain extract: studies on cyclic 3′,5′-nucleotide phosphodiesterase (II). Proc. Jpn. Acad. 46, 587–592.

    Google Scholar 

  8. Kakiuchi, S., Yamazaki, R., andTeshima, Y. (1972) Regulation of brain phosphodiesterase activity: Ca2+ plus Mg2+-dependent phosphodiesterase and its activating factor from rat brain.In Greengard, P., Paoletti, R., andG.A. Robison, (eds.), Advances in Cyclic Nucleotide Research, Vol. 1, Raven Press, New York, pp. 455–477.

    Google Scholar 

  9. Kakiuchi, S., Yamazaki, R., Teshima, Y., andUenishi, K. (1973) Regulation of nucleoside cyclic 3′,5′-monophosphate phosphodiesterase activity from rat brain by a modulator and Ca2+. Proc. Natl. Acad. Sci. U.S.A. 70, 3526–3530.

    PubMed  Google Scholar 

  10. Uzunov, P., Revuelta, A.V., andCosta, E. (1975)In vitro regulation of cyclic 3′,5′-adenosine-monophosphate content by changes in the endogenous phosphodiesterase activator. Fed. Proc. Fed. Am. Soc. Exp. Biol. 34, 261.

    Google Scholar 

  11. Uzunov, P., Revuelta, A., andCosta, E. (1975) A role for the endogenous activator of 3′,5′-nucleotide phosphodiesterase in rat adrenal medulla. Mol. Pharmacol. 11, 506–510.

    Google Scholar 

  12. Uzunov, P., Gnegy, M., Lehne, R., Revuelta, A., andCosta, E. (1976) A neurobiological role for a protein activator of cyclic nucleotide phosphodiesterase.In Costa, E., Paoletti, R., andGiacobini, E. (eds.), Advances in Biochemical Psychopharmacology, Vol. 16, Raven Press, New York (in press).

    Google Scholar 

  13. Gnegy, M., Costa, E., andUzunov, P. (1976) The regulation of the transsynaptically elicited increase of 3′,5′-cyclic AMP by the endogenous phosphodiesterase activator. Proc. Nat. Acad. Sci. U.S.A. 73, 352–355.

    Google Scholar 

  14. Kuo, J.F. andGreengard, P. (1972) An assay method for cyclic AMP and cyclic GMP based upon their abilities to activate cyclic GMP-dependent protein kinase.In Greengard, P., Robison, G.A., andPaoletti, R. (eds.), Advances in Cyclic Nucleotide Research, Vol. 2, Raven Press, New York, pp. 41–50.

    Google Scholar 

  15. Filburn, C.R., andKarn, J. (1973) An isotopic assay of cyclic 3′,5′-nucleotide phosphodiesterase with aluminum oxide columns. Anal. Biochem. 52, 505–516.

    PubMed  Google Scholar 

  16. Krishna, G., Weiss, B., andBrodie, B.B. (1968) A simple sensitive method for the assay of adenyl cyclase. J. Pharmacol. Exp. Ther. 163, 379–385.

    PubMed  Google Scholar 

  17. Kakiuchi, S., andRall, T.W. (1965) Effects of norepinephrine (NE) and histamine (H) on levels of adenosine 3′,5′-phosphate (3,5-AMP) in brain slices. Fed. Proc. Fed. Am. Soc. Exp. Bicl. 24, 150.

    Google Scholar 

  18. Kakiuchi, S., andRall, T.W. (1968) The influence of chemical agents on the accumulation of adenosine 3′,5′-phosphate in slices of rabbit cerebellum. Mol. Pharmacol. 4, 367–378.

    PubMed  Google Scholar 

  19. Huang, M., andDaly, J.W. (1972) Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. I. Structure-activity relationships of agonists and antagonists of biogenic amines and of tricyclic tranquilizers and antidepressants. J. Med. Chem. 15, 458–461.

    PubMed  Google Scholar 

  20. Palmer, G.C., Sulser, F. andRobison, G.A. (1969) The effect of neurohumoral agents on the level of cAMP in different brain areas in vitro. Pharmacologist 11, 258.

    Google Scholar 

  21. Walker, J.B., andWalker, J.P. (1973) Neurohumoral regulation of adenylate cyclase activity in rat striatum. Brain Res. 54, 386–390.

    PubMed  Google Scholar 

  22. Shimizu, H., Daly, J.W., andCreveling, C.R. (1969) A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. J. Neurochem. 16, 1609–1619.

    PubMed  Google Scholar 

  23. Shimizu, H., Creveling, C.R., andDaly, J.W. (1970) Stimulated formation of adenosine 3′,5′-cyclic phosphate in cerebral cortex: synergism between electrical activity and biogenic amines. Proc. Nat. Acad. Sci. U.S.A. 65, 1033–1040.

    Google Scholar 

  24. Perkins J.P., andMoore, M.M. (1973) Characterization of the adrenergic receptors mediating a rise in cyclic 3′,5′-adenosine monophosphate in rat cerebral cortex. J. Pharmacol. Exp. Therap. 185, 371–378.

    Google Scholar 

  25. Ferrendelli, J.A., Kinscherf, D.A., andChang, M.M. (1973) Regulation of levels of guanosine cyclic 3′,5′-monophosphate in the central nervous system: effects of depolarizing agents. Mol. Pharmacol. 9, 445–454.

    PubMed  Google Scholar 

  26. Shimizu, H., Creveling, C.R., andDaly, J.W. (1970) The effect of histamines and other compounds on the formation of adenosine 3′,5′-monophosphate in slices from cerebral cortex. j. Neurochem. 17, 441–444

    PubMed  Google Scholar 

  27. Forn, J., andKrishna, G. (1970) Effects of biological amines on the rate of adenosine 3′,5′-monophosphate (3′,5′-AMP) formation in brain slices of different animal species. Fed. Proc. Fed. Am. Soc. Exp. Biol. 29, 480.

    Google Scholar 

  28. Uzunov, P., andWeiss, B (1972) Psychopharmacological agents and the cyclic AMP system of rat brain.In Greengard, P., andRobison, G.A. (eds.), Advances in Cyclic Nucleotide Research, Vol. 1, Raven Press, New York pp. 435–453.

    Google Scholar 

  29. Klainer, L.M., Chi, Y.-M., Freidberg, S.L., Rall, T.W., andSutherland, E.W. (1962) Adenylcyclase. IV. The effects of neurohormones on the formation of adenosine 3′,5′-phosphate by preparations from brain and other tissues. J. Biol. Chem. 237, 1239–1243.

    PubMed  Google Scholar 

  30. Voigt, K.M., andKrishna, G. (1967) Correlation between the distribution of adenyl cyclase, cyclic 3′,5′AMP phosphodiesterase and various biological amines in various areas of the brain. Pharmacologist 9, 239.

    Google Scholar 

  31. Burkard, W.P., andGey, K.F. (1968) Adenylcyclase in Rattenherz. Helv. Physiol. Pharmacol. Acta 26, CR197-CR198.

    PubMed  Google Scholar 

  32. Williams, R.H. Little, S.A., andEnsinck, J.W. (1969) Adenyl cyclase and phosphodiesterase activities in brain areas of man, monkey and rat. Am. J. Med. Sci. 258, 190–202.

    PubMed  Google Scholar 

  33. McCune, R.W., Gill, T.H., von Hungen, K., andRoberts, S. (1971) Catecholamine-sensitive adenyl cyclase in cell-free preparations from rat cerebral cortex. Life Sci. 10, (II) 443–450.

    Google Scholar 

  34. Von Hungen, K., andRoberts, S. (1973) Catecholamine and Ca2+ activation of adenylate cyclase systems in synaptosomal fractions from rat cerebral, cortex. Nature, New Biology 242, 58–60.

    Google Scholar 

  35. Von Hungen, K., andRoberts, S. (1973) Adenylate cyclase receptor for adrenergic neurotransmitters in rat cerebral cortex. Eur. J. Biochem. 36, 391–401.

    PubMed  Google Scholar 

  36. Kebabian, J.W., Petzold, G.L., andGreengard, P. (1972) Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain and its, similarity to the “dopamine receptor”. Proc. Natl. Acad. Sci. U.S.A. 69, 2145–2149.

    PubMed  Google Scholar 

  37. Maeno, H., Ueda, T., andGreengard, P. (1975) Adenosine 3′,5′-monophosphate-dependent protein phosphatase activity in synaptic membrane fractions. J. Cyclic Nucleotide Res. 1, 37–48.

    Google Scholar 

  38. Ueda, T., Maeno, H., andGreengard, P. (1973) Regulation of endogenous phosphorylation of specific proteins in synaptic membrane fractions from rat brain by adenosine 3′,5′-monophosphate. J. Biol. Chem. 248, 8295–8305.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Preclinical Pharmacology National Institute of Mental Health, Saint Elizabeths Hospital, 20032, Washington D.C.

    A. Revuelta, P. Uzunov & E. Costa

Authors
  1. A. Revuelta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Uzunov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Revuelta, A., Uzunov, P. & Costa, E. Release of phosphodiesterase activator from particulate fractions of cerebellum and striatum by putative neurotransmitters. Neurochem Res 1, 217–227 (1976). https://doi.org/10.1007/BF00966112

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00966112

Keywords

Search

Navigation